Geneos Wealth Management Inc. trimmed its position in shares of Welltower Inc. (NYSE:WELL – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,508 shares of the real estate investment trust’s stock after selling 319 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Welltower were worth $820,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in the company. Laurel Wealth Advisors LLC acquired a new position in shares of Welltower in the fourth quarter valued at approximately $25,000. Fortitude Family Office LLC grew its holdings in Welltower by 37.0% in the 3rd quarter. Fortitude Family Office LLC now owns 289 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 78 shares in the last quarter. Versant Capital Management Inc increased its position in Welltower by 165.5% during the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 187 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Welltower during the third quarter worth $50,000. Finally, FSA Wealth Management LLC bought a new stake in shares of Welltower in the third quarter valued at about $59,000. Institutional investors own 94.80% of the company’s stock.
Analyst Ratings Changes
Several research analysts have recently commented on WELL shares. Raymond James raised their target price on shares of Welltower from $145.00 to $155.00 and gave the stock a “strong-buy” rating in a report on Monday, December 16th. StockNews.com upgraded Welltower from a “sell” rating to a “hold” rating in a research report on Wednesday, October 30th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $135.00 target price (up previously from $134.00) on shares of Welltower in a research report on Tuesday, October 1st. Scotiabank lifted their price target on shares of Welltower from $142.00 to $144.00 and gave the company a “sector outperform” rating in a report on Monday. Finally, Bank of America increased their price target on Welltower from $190.00 to $221.00 and gave the company a “buy” rating in a research note on Friday. Five analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $134.96.
Welltower Stock Performance
Shares of WELL opened at $138.32 on Tuesday. The firm’s fifty day simple moving average is $130.12 and its two-hundred day simple moving average is $125.52. Welltower Inc. has a 12 month low of $85.40 and a 12 month high of $140.75. The stock has a market capitalization of $86.13 billion, a P/E ratio of 91.00, a price-to-earnings-growth ratio of 2.64 and a beta of 1.22. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.
Welltower (NYSE:WELL – Get Free Report) last posted its quarterly earnings results on Monday, October 28th. The real estate investment trust reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.31). Welltower had a return on equity of 3.20% and a net margin of 12.22%. The company had revenue of $2.06 billion during the quarter, compared to analyst estimates of $1.95 billion. During the same quarter in the previous year, the business posted $0.92 earnings per share. The company’s revenue for the quarter was up 23.7% compared to the same quarter last year. As a group, analysts predict that Welltower Inc. will post 4.3 EPS for the current year.
Welltower Profile
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
Featured Articles
- Five stocks we like better than Welltower
- ETF Screener: Uses and Step-by-Step Guide
- Sizing Up a New Opportunity for NVIDIA Investors
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What is the Nikkei 225 index?
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding WELL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Welltower Inc. (NYSE:WELL – Free Report).
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.